HIV remains a global burden and without an effective vaccine, it is crucial to develop microbicides to halt the initial transmission of the virus. Several microbicides have been researched with various levels of success. Amongst these microbicides, the broadly neutralising antibodies and peptide lectins are promising in that they can immediately act on the virus and have proven efficacious in in vitro and in vivo protection studies. For the purpose of development and access by the relevant population groups, it is crucial that these microbicides be produced at low cost. For the promising protein and peptide candidate molecules, it appears that current production systems are overburdened and expensive to establish and maintain. With recent developments in vector systems for protein expression coupled with downstream protein purification technologies, plants are gaining credibility as alternative production systems. Here we evaluate the advances made in plant expression host and vector system development as well as the progress made in expressing HIV neutralising antibodies and peptide lectins using plant-based platforms.
Reference:
Lotter-Stark, H.C.T, Rybick, E.P and Chikwamba, R.K. 2012. Plant made anti-HIV microbicides: a field of opportunity. Biotechnology Advances, vol. 30(6), pp 1614-1624
Lotter-Stark, H., Rybick, E., & Chikwamba, R. K. (2012). Plant made anti-HIV microbicides: a field of opportunity. http://hdl.handle.net/10204/7698
Lotter-Stark, HCT, EP Rybick, and Rachel K Chikwamba "Plant made anti-HIV microbicides: a field of opportunity." (2012) http://hdl.handle.net/10204/7698
Lotter-Stark H, Rybick E, Chikwamba RK. Plant made anti-HIV microbicides: a field of opportunity. 2012; http://hdl.handle.net/10204/7698.
Copyright: 2012 Elsevier. This is the pre/post print version of the work. The definitive version is published in Biotechnology Advances, vol. 30(6), pp 1614-1626